What are the risks of histoplasmosis exposure from contact with earth or soil in Illinois, United States of America (USA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Histoplasmosis exposure is a concern in Illinois due to the presence of Histoplasma capsulatum fungus in soil, particularly in areas with bird or bat droppings, and individuals should monitor for symptoms and take preventive measures to minimize risk, as recommended by the Infectious Diseases Society of America 1.

Key Considerations

  • If you've been exposed to disturbed earth in Illinois, monitor for symptoms including fever, cough, fatigue, chest pain, and joint pain, which typically appear 3-17 days after exposure.
  • Most healthy individuals will clear the infection without treatment, but if symptoms develop, seek medical evaluation.
  • For confirmed infections, treatment depends on severity, with mild cases potentially not requiring medication, while more significant infections typically require antifungal treatment with itraconazole (200-400 mg daily for 6-12 weeks) or, in severe cases, amphotericin B followed by itraconazole, as outlined in the guidelines for the management of patients with histoplasmosis 1.

Preventive Measures

  • When working in high-risk areas like construction sites, chicken coops, or caves in Illinois, preventive measures include:
    • Wearing N95 respirators
    • Wetting soil before disturbing it
    • Avoiding activities that generate dust
  • People with compromised immune systems should take extra precautions as they face higher risk of developing disseminated disease from exposure, as noted in the guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents 1.

Treatment and Management

  • The treatment of histoplasmosis depends on the severity of the disease, with amphotericin B formulations recommended for severe or moderately severe cases, and itraconazole for less severe cases, as recommended by the Infectious Diseases Society of America 1.
  • Patients with severe or moderately severe histoplasmosis should be treated with an amphotericin B formulation initially, with monitoring of electrolyte levels, renal function, and blood cell count, as outlined in the clinical practice guidelines for the management of patients with histoplasmosis 1.

From the Research

Illinois Exposure to Earth Ground Histoplasmosis

  • Histoplasmosis is a fungal infection caused by the dimorphic fungus Histoplasma capsulatum, which can be found in soil and is often associated with bird and bat droppings 2.
  • The disease can be acquired through inhalation of the conidia, and its severity can range from mild to severe, potentially fatal cases 3.
  • Treatment options for histoplasmosis include amphotericin B, itraconazole, and posaconazole, among others 4, 5, 6.
  • In cases where first-line and second-line therapies have failed or are contraindicated, alternative treatments such as isavuconazole may be considered 2.
  • The effectiveness of these treatments can vary depending on the severity of the disease, the patient's immune status, and other factors 5, 6.
  • Studies have shown that posaconazole can be an effective treatment option for histoplasmosis, including in immunocompromised patients 4, 6.
  • However, the choice of treatment should be based on individual patient needs and circumstances, and guided by clinical guidelines and expert recommendations 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Blastomycosis.

Seminars in respiratory and critical care medicine, 2020

Research

Salvage treatment of histoplasmosis with posaconazole.

The Journal of infection, 2007

Research

Voriconazole Versus Itraconazole for the Initial and Step-down Treatment of Histoplasmosis: A Retrospective Cohort.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.